The clear correlation of EPAS1 with increased patient survival, low-risk tumors, and noradrenergic differentiation prompted us to test whether increased levels of HIF2α in neuroblastoma cells would affect key cellular properties such as proliferation and differentiation. Here, EPAS1 is linked to neuroblastoma.